Ligand validation:8XF1

CYC: PHYCOCYANOBILIN

CYC is a Ligand Of Interest in 8XF1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8XF1_CYC_A_201	64%	5%	0.126	0.924	3.52	1.89	24	13	2	0	100%	1
8XF1_CYC_A_202	59%	5%	0.132	0.913	3.55	1.73	19	13	1	0	100%	1
7EFW_CYC_B_202	88%	5%	0.074	0.95	3.76	1.77	20	9	1	0	100%	1
8XF2_CYC_G_201	75%	5%	0.117	0.951	3.58	1.74	19	11	2	0	100%	1
8XF3_CYC_C_201	73%	5%	0.138	0.964	3.68	1.79	20	11	2	0	100%	1
7EFV_CYC_C_201	51%	4%	0.207	0.962	3.74	1.81	20	9	3	0	100%	1
6XWK_CYC_AAA_201	98%	41%	0.06	0.984	1.16	1.12	2	3	0	0	100%	1
6YX7_CYC_CCC_201	97%	34%	0.055	0.971	1.24	1.37	1	8	0	0	100%	1
7T89_CYC_A_101	96%	16%	0.07	0.98	2.16	1.58	12	8	0	0	100%	0.76
1PHN_CYC_A_184	96%	9%	0.062	0.968	1.56	2.93	6	13	2	0	100%	1
3L0F_CYC_A_484	95%	6%	0.076	0.979	2.15	2.85	10	19	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.